Moderna expects $1.9 billion in sales, trims costs forecast for 2025

Core Viewpoint - Moderna expects to report approximately $1.9 billion in sales for 2025, which is near the upper end of its previously projected range of $1.6 billion to $2 billion, but significantly lower than revenue levels achieved during the COVID-19 pandemic [1] Financial Projections - The projected sales for 2025 are positioned at $1.9 billion, indicating a strong outlook within the previously set forecast range [1] - The anticipated revenue remains well below the peak levels experienced during the COVID-19 pandemic, highlighting a shift in market dynamics [1]